Helius Medical Technologies Inc HSDT

Healthcare Medical Devices

Helius Medical Technologies, Inc. is a neurotech company in the medical device field. It is focused on neurologic deficits using orally applied technology platform that amplifies the brain’s ability to engage physiologic compensatory mechanisms enhancing the lives of people dealing with neurologic diseases. It develops, licenses, or acquires non-implantable technologies targeted at reducing symptoms of neurological disease or trauma. Its product Portable Neuromodulation Stimulator (PoNS) is a non-implantable medical device, inclusive of a controller and mouthpiece, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. PoNS Therapy is integral to the overall PoNS solution and is the physical therapy applied by patients during use of the PoNS neuromodulation stimulator. PoNS is used as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and over by prescription only.

NDAQ:HSDT - Post by User

Helius Medical Technologies Inc

Bullboard Posts

Comment by miningfundion Dec 05, 2017 2:11pm

124 Views

Post# 27095278

RE:Another Director Buys Shares in the Open Market

Neither Andreeff nor Blane have yet filed their HSM share purchases on SEDI (required to file within 5 days). Andreeff has not even filed as a director (required to file within 10 days). Another sign of inadequate reporting - not a confidence builder.

prokofiev wrote: Director Walter R Blane recently bought 40,000 shares at $3.08. This is the now the second Director to buy shares following the release of the trial results.

Prokofiev